Back to companies
Ensysce Biosciences, Inc.
ENSCUSNASDAQPharmaceuticals & HealthcareEnsysce Biosciences, Inc.
Revenue
$5.1mn
YoY -2.8%
Operating income
-$10.2mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API